The Novartis Commitment to Patients and Caregivers
We recognize the importance of patients and caregivers understanding what they can expect from Novartis.
From the inception of a therapeutic through early clinical development, our disease area teams collaborate across scientific disciplines and organizations in support of our mission to improve and extend peoples’ lives.
Novartis believes that medicines should be available to all who need them. We have a variety of programs to help support patients and make it easier for them to afford their medicines.
The STEP Program™
Novartis developed the STEP (Solutions to Empower Patients) ProgramTM to fund innovative projects from United States (US)–based nonprofit organizations that help address some of the most pressing gaps between best practices and the care a patient - or caregiver - actually receives. By supporting the patient advocacy organizations that are best positioned to address these unmet needs, our goal is to help reduce the burden of disease and help create a path to better care.
Participating in Novartis Clinical Trials
Clinical trials are critical to the development of new treatments for patients. Novartis is currently conducting clinical trials in the US and around the world for a number of diseases.
Adverse Event Reporting
Reporting suspected side effects of the medicinal product is important to Novartis.